Rare diseases
Investigational molecules
Locations
A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
PortugalEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
PortugalA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
PortugalA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
PortugalStudy comparing two forms of cagrilintide with placebo for weight loss in adults with overweight or obesity
PortugalEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
PortugalA Study to Assess Safety and Efficacy of Surzetoclax Alone or with Etentamig in Adults with Relapsed or Refractory Multiple Myeloma
PortugalSafety, Pharmacokinetics, and Exploratory Efficacy of BI 1015550 and Nerandomilast in Children and Adolescents Aged 2‑17 Years With Fibrosing Interstitial Lung Disease
PortugalEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
PortugalStudy of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer
PortugalVenetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
PortugalA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
